Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.
暂无分享,去创建一个
Y. Ko | Tsu‐Nai Wang | Meng-Chuan Huang | Wen-Tsan Chang | Yi-Chia Huang | Yi-Ling Liu | Temin Pa | Hung-Ping Tu | Yi-Chia Huang | Tsu-Nai Wang
[1] A. Hedley,et al. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. , 2004, Obesity research.
[2] S. Kihara,et al. Adiponectin as a biomarker of the metabolic syndrome. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[3] M. Fujita,et al. Low Serum α-Tocopherol Concentrations in Subjects With Various Coronary Risk Factors , 2004 .
[4] S. Fried,et al. Sugars, hypertriglyceridemia, and cardiovascular disease. , 2003, The American journal of clinical nutrition.
[5] P. Stiefel,et al. Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism. , 2003, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[6] R. Narang,et al. Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians , 2002, BMC Genetics.
[7] D. Corella,et al. Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus. , 2002, Journal of lipid research.
[8] P. Wilson,et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. , 2001, Atherosclerosis.
[9] R. Hamman,et al. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels , 2000, Human Genetics.
[10] P. Amouyel,et al. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France. , 2000, Atherosclerosis.
[11] J. Kao,et al. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index. , 2000, Journal of the Formosan Medical Association = Taiwan yi zhi.
[12] J. Ribalta,et al. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. , 1999, Circulation.
[13] J. Carlquist,et al. Association of lipoprotein lipase gene polymorphisms with coronary artery disease. , 1999, Journal of the American College of Cardiology.
[14] J. Ordovás,et al. Genes, variation of cholesterol and fat intake and serum lipids. , 1999, Current opinion in lipidology.
[15] J. Ordovás,et al. The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. , 1998, The American journal of clinical nutrition.
[16] P. Talmud,et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[17] J. Hokanson,et al. Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.
[18] G. Assmann,et al. The Münster Heart Study (PROCAM). Results of follow-up at 8 years. , 1998, European heart journal.
[19] Y. Ko,et al. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese , 1997, Human Genetics.
[20] J. Rotter,et al. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. , 1997, The Journal of clinical investigation.
[21] N. Cox,et al. Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children , 1996, Human Genetics.
[22] J. Breslow. Mouse Models of Atherosclerosis , 1996, Science.
[23] M. Hayden,et al. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. , 1996, Journal of lipid research.
[24] J. Breslow,et al. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. , 1995, The Journal of clinical investigation.
[25] M. Stoneking,et al. Polynesian genetic affinities with Southeast Asian populations as identified by mtDNA analysis. , 1995, American journal of human genetics.
[26] R. Winter,et al. Previously apparently undescribed syndrome: shallow orbits, ptosis, coloboma, trigonocephaly, gyral malformations, and mental and growth retardation. , 1995, American journal of medical genetics.
[27] J. Sasaki,et al. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population , 1995, Human Genetics.
[28] Y. Ko,et al. [Issues on aboriginal health in Taiwan]. , 1994, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.
[29] A. Deev,et al. The association of education with coronary heart disease mortality in the USSR Lipid Research Clinics Study. , 1993, International journal of epidemiology.
[30] J. Breslow,et al. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Humphries,et al. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. , 1993, Atherosclerosis.
[32] S. Humphries,et al. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. , 1992, Atherosclerosis.
[33] P. Bellwood,et al. The Austronesian Dispersal and the Origin of Languages , 1991 .
[34] C. Shoulders,et al. Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII. , 1991, Atherosclerosis.
[35] K. Johansen,et al. Coronary artery disease and apolipoprotein A‐I/C‐III gene polymorphism: a study of Saudi Arabians , 1991, Clinical genetics.
[36] D. Galton,et al. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. , 1989, Atherosclerosis.
[37] P. Wenham,et al. DNA RESTRICTION FRAGMENT LENGTH POLYMORPHISMS AS MARKERS OF FAMILIAL CORONARY HEART DISEASE , 1989, The Lancet.
[38] D. Galton,et al. A DNA polymorphism of the apolipoprotein C-III gene in extracoronary atherosclerosis. , 1988, Clinical science.
[39] T. Mohandas,et al. Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. , 1987, Genomics.
[40] C. Vergani,et al. Restriction-fragment-length polymorphisms in the A-I-C-III gene complex occurring in a family with hypoalphalipoproteinemia. , 1986, Atherosclerosis.
[41] D. Galton,et al. haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia , 1986, Human Genetics.
[42] A. Camm,et al. DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. , 1985, Atherosclerosis.
[43] S. Karathanasis. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Galton,et al. GENETIC POLYMORPHISMS OF APOLIPOPROTEIN C-III AND INSULIN IN SURVIVORS OF MYOCARDIAL INFARCTION , 1985, The Lancet.
[45] C. S. Wang,et al. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. , 1985, The Journal of clinical investigation.
[46] B. Kamel,et al. Food habits and nutrient intake of Kuwaiti males and females , 1984 .
[47] G. Bruns,et al. Human Apolipoprotein A‐I‐C‐III Gene Complex is Located on Chromosome II , 1984, Arteriosclerosis.
[48] C. Shoulders,et al. DNA POLYMORPHISM ADJACENT TO HUMAN APOPROTEIN A-1 GENE: RELATION TO HYPERTRIGLYCERIDAEMIA , 1983, The Lancet.
[49] G. Schonfeld,et al. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. , 1979, Metabolism: clinical and experimental.
[50] S. Livingston,et al. ONE-DRUG REGIMENS FOR EPILEPSY , 1976, The Lancet.
[51] H. Yatsuya,et al. Long-term body weight fluctuation is associated with metabolic syndrome independent of current body mass index among Japanese men. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[52] M. Fujita,et al. Low serum alpha-tocopherol concentrations in subjects with various coronary risk factors. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[53] K. Arakawa,et al. Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population , 2004, Human Genetics.
[54] Jin Q. Kim,et al. Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. , 1997, Clinical chemistry.
[55] J. Rotter,et al. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. , 1996, Journal of lipid research.
[56] Robert Blust,et al. The Austronesian Homeland: A Linguistic Perspective , 1985 .
[57] A. Shaw. Letter: Another blood product. , 1974, Lancet.